返回
Sex Differences in Immunity
DOI:10.1146/annurev-immunol-101320-125133.png)
摘要
En 中文
Strong epidemiological evidence now exists that sex is an important biologic variable in immunity. Recent studies, for example, have revealed that sex differences are associated with the severity of symptoms and mortality due to coronavirus disease 2019 (COVID-19). Despite this evidence, much remains to be learned about the mechanisms underlying associations between sex differences and immune-mediated conditions. A growing body of experimental data has made significant inroads into understanding sex-influenced immune responses. As physicians seek to provide more targeted patient care, it is critical to understand how sex-defining factors (e.g., chromosomes, gonadal hormones) alter immune responses in health and disease. In this review, we highlight recent insights into sex differences in autoimmunity; virus infection, specifically severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; and cancer immunotherapy. A deeper understanding of underlying mechanisms will allow the development of a sex-based approach to disease screening and treatment.
Keyword:
immunity
chromosomal complement
sex hormones
sex differences
autoimmunity
immune-related adverse events
期刊
IF:
33.3
论文数:
775
被引数:
2.0W
机构
引用论文
Synthesis and characterization of ZnS:Mn/ZnS core/shell nanoparticles for tumor targeting and imaging in vivoZnS:Mn/ZnS核/壳纳米粒子的合成与表征,用于肿瘤靶向和体内成像
Evaluating sex as a biological variable in preclinical research: the devil in the details在临床前研究中评估性别作为生物学变量: 细节中的魔鬼
Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment免疫检查点抑制剂治疗后甲状腺免疫相关不良事件
Testosterone is an endogenous regulator of BAFF and splenic B cell number
NATURE COMMUNICATIONS
IF15.7
The CD40-CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis实验性自身免疫性脑脊髓炎和多发性硬化的CD40-CD40L Dyad

